Show simple item record

The poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib.

dc.contributor.authorO'Sullivan, JM
dc.contributor.authorHamblin, A
dc.contributor.authorYap, C
dc.contributor.authorFox, S
dc.contributor.authorBoucher, R
dc.contributor.authorPanchal, A
dc.contributor.authorAlimam, S
dc.contributor.authorDreau, H
dc.contributor.authorHoward, K
dc.contributor.authorWare, P
dc.contributor.authorCross, NCP
dc.contributor.authorMcMullin, MF
dc.contributor.authorHarrison, CN
dc.contributor.authorMead, AJ
dc.date.accessioned2019-10-21T10:03:09Z
dc.date.issued2019-12
dc.identifier.citationBlood, 2019, 134 (23), pp. 2107 - 2111
dc.identifier.issn0006-4971
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/3385
dc.identifier.eissn1528-0020
dc.identifier.doi10.1182/blood.2019001861
dc.formatPrint
dc.format.extent2107 - 2111
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
dc.subjectHumans
dc.subjectHydroxyurea
dc.subjectPyrazoles
dc.subjectDisease-Free Survival
dc.subjectSurvival Rate
dc.subjectRisk Factors
dc.subjectDrug Resistance
dc.subjectFemale
dc.subjectMale
dc.subjectThrombocythemia, Essential
dc.titleThe poor outcome in high molecular risk, hydroxycarbamide-resistant/intolerant ET is not ameliorated by ruxolitinib.
dc.typeJournal Article
rioxxterms.versionofrecord10.1182/blood.2019001861
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/under-embargo-all-rights-reserved
rioxxterms.licenseref.startdate2019-12
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfBlood
pubs.issue23
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical Trials & Statistics Unit
pubs.publication-statusPublished
pubs.volume134
pubs.embargo.termsNot known
icr.researchteamClinical Trials & Statistics Uniten_US
dc.contributor.icrauthorYap, Christinaen


Files in this item

Thumbnail
Name:
blood.2019001861.pdf
Size:
693.2Kb
Format:
PDF
Description:
Published version
View/Open

This item appears in the following collection(s)

Show simple item record